Common Names: urn orchid
Researchers developed a hydrogel using natural compounds that promotes wound healing in diabetic mice by enhancing angiogenesis, reducing inflammation, and promoting collagen regeneration. This discovery may lead to new diabetic wound treatments.
Researchers used a polysaccharide-vitamin E succinate polymer to improve tumor targeting and anti-colon cancer effects of andrographolide. This novel delivery system shows promise for cancer treatment.
Researchers isolated novel compounds from Bletilla striata tubers and found two that inhibit neuroinflammation by targeting the AKT/IκB/NF-κB pathway and PTP1B overexpression. Potential for treating neuroinflammatory diseases.
Researchers developed a innovative wound dressing using a self-healing hydrogel with nanoparticles to fight infection and promote healing in diabetic ulcers. It shows promising results in studies and may have clinical benefits.
Bletilla striata polysaccharides (BSP) reduced weight gain in obese mice on a high-fat diet, as well as improving gut microbiota and metabolomic profile. BSP could be a potential treatment for obesity.
BSP, a component of Bletilla Striata plant, was tested in mice for its effects on inflammation, antioxidant levels, pain relief, and wound healing. Results showed BSP reduced inflammation, improved antioxidant levels, relieved pain, and promoted wound healing by inhibiting inflammatory cytokines.
Scientists developed a composite hydrogel dressing for diabetic wounds. The hydrogel demonstrated antibacterial, anti-inflammatory, and antioxidant properties. Animal experiments showed significant acceleration of wound healing. This hydrogel has great potential for clinical use.
Researchers discovered four new neolignan glycosides in Bletilla striata, which showed promising neuroprotective effects against glutamate-induced PC12 cell injury. These compounds are the first of their kind found in the genus Bletilla, indicating the potential of Bletilla striata as a source of anti-neurodegenerative agents.